George G. Li

Neurology

4161 Tamiami Trl Ste 201
Port Charlotte, FL 33952

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 3 publications

Subcutaneous efgartigimod PH20 in generalized myasthenia gravis: A phase 3 randomized noninferiority study (ADAPT-SC) and interim analyses of a long-term open-label extension study (ADAPT-SC+).

Subcutaneous efgartigimod PH20 in generalized myasthenia gravis: A phase 3 randomized noninferiority study (ADAPT-SC) and interim analyses of a long-term open-label extension study (ADAPT-SC+).

Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

Published: November 14, 2023

Oral ENT-01 Targets Enteric Neurons to Treat Constipation in Parkinson Disease : A Randomized Controlled Trial.

Oral ENT-01 Targets Enteric Neurons to Treat Constipation in Parkinson Disease : A Randomized Controlled Trial.

Journal: Annals of internal medicine

Published: November 07, 2022

Targeting neurons in the gastrointestinal tract to treat Parkinson's disease.

Targeting neurons in the gastrointestinal tract to treat Parkinson's disease.

Journal: Clinical parkinsonism & related disorders

Published: June 07, 2019

Showing 1-3 of 3

Last Updated: 09/26/2026